Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: A North American Brain Tumor Consortium study Article

Jaeckle, KA, Hess, KR, Yung, WKA et al. (2003). Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: A North American Brain Tumor Consortium study . JOURNAL OF CLINICAL ONCOLOGY, 21(12), 2305-2311. 10.1200/JCO.2003.12.097

cited authors

  • Jaeckle, KA; Hess, KR; Yung, WKA; Greenberg, H; Fine, H; Schiff, D; Pollack, IF; Kuhn, J; Fink, K; Mehta, M; Cloughesy, T; Nicholas, MK; Chang, S; Prados, M

sustainable development goals

authors

publication date

  • June 15, 2003

webpage

published in

keywords

  • 1ST RELAPSE
  • ANTITUMOR IMIDAZOTETRAZINES
  • ASTROCYTOMA-CELLS
  • CELL-LINES
  • CHEMOTHERAPY
  • IN-VITRO
  • Life Sciences & Biomedicine
  • Oncology
  • PROLIFERATION
  • RADIATION-THERAPY
  • Science & Technology
  • TRANS-RETINOIC ACID
  • XENOGRAFTS

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 2305

end page

  • 2311

volume

  • 21

issue

  • 12